Persistence of remission after lengthening of golimumab in inflammatory joint diseases. Damiani A, Bartoli F, Pacini G, Carboni D, et al. Clin Exp Rheumatol 2023;41:1088-1095.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Damiani A, Bartoli F, Pacini G, Carboni D, et al. Persistence of remission after lengthening of golimumab in inflammatory joint diseases. Clin Exp Rheumatol 2023;41:1088-1095.
PMID: 36622116